Result Number | Material Type | Add to My Shelf Action | Record Details and Options |
---|---|---|---|
1 |
Material Type: Artigo
|
Pembrolizumab for Early Triple-Negative Breast CancerSchmid, Peter ; Cortes, Javier ; Pusztai, Lajos ; McArthur, Heather ; Kümmel, Sherko ; Bergh, Jonas ; Denkert, Carsten ; Park, Yeon Hee ; Hui, Rina ; Harbeck, Nadia ; Takahashi, Masato ; Foukakis, Theodoros ; Fasching, Peter A ; Cardoso, Fatima ; Untch, Michael ; Jia, Liyi ; Karantza, Vassiliki ; Zhao, Jing ; Aktan, Gursel ; Dent, Rebecca ; O’Shaughnessy, JoyceThe New England journal of medicine, 2020-02, Vol.382 (9), p.810-821 [Periódico revisado por pares]United States: Massachusetts Medical SocietyTexto completo disponível |
|
2 |
Material Type: Artigo
|
Molecular alterations in triple-negative breast cancer—the road to new treatment strategiesDenkert, Carsten, Dr ; Liedtke, Cornelia, MD ; Tutt, Andrew, MD ; von Minckwitz, Gunter, MDThe Lancet (British edition), 2017-06, Vol.389 (10087), p.2430-2442 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
3 |
Material Type: Artigo
|
Tumor infiltrating lymphocytes in early breast cancerPruneri, Giancarlo, MD ; Vingiani, Andrea, MD ; Denkert, Carsten, MDBreast (Edinburgh), 2018-02, Vol.37, p.207-214 [Periódico revisado por pares]Netherlands: Elsevier LtdTexto completo disponível |
|
4 |
Material Type: Artigo
|
Clinical relevance of host immunity in breast cancer: from TILs to the clinicSavas, Peter ; Salgado, Roberto ; Denkert, Carsten ; Sotiriou, Christos ; Darcy, Phillip K ; Smyth, Mark J ; Loi, ShereneNature reviews. Clinical oncology, 2016-04, Vol.13 (4), p.228-241 [Periódico revisado por pares]England: Nature Publishing GroupTexto completo disponível |
|
5 |
Material Type: Artigo
|
An online survival analysis tool to rapidly assess the effect of 22,277 genes on breast cancer prognosis using microarray data of 1,809 patientsGyörffy, Balazs ; Lanczky, Andras ; Eklund, Aron C. ; Denkert, Carsten ; Budczies, Jan ; Li, Qiyuan ; Szallasi, ZoltanBreast cancer research and treatment, 2010-10, Vol.123 (3), p.725-731 [Periódico revisado por pares]Boston: Springer USTexto completo disponível |
|
6 |
Material Type: Artigo
|
Neoadjuvant Chemotherapy and Bevacizumab for HER2-Negative Breast Cancervon Minckwitz, Gunter ; Eidtmann, Holger ; Rezai, Mahdi ; Fasching, Peter A ; Tesch, Hans ; Eggemann, Holm ; Schrader, Iris ; Kittel, Kornelia ; Hanusch, Claus ; Kreienberg, Rolf ; Solbach, Christine ; Gerber, Bernd ; Jackisch, Christian ; Kunz, Georg ; Blohmer, Jens-Uwe ; Huober, Jens ; Hauschild, Maik ; Fehm, Tanja ; Müller, Berit Maria ; Denkert, Carsten ; Loibl, Sibylle ; Nekljudova, Valentina ; Untch, MichaelThe New England journal of medicine, 2012-01, Vol.366 (4), p.299-309 [Periódico revisado por pares]Waltham, MA: Massachusetts Medical SocietyTexto completo disponível |
|
7 |
Material Type: Artigo
|
Cutoff Finder: a comprehensive and straightforward Web application enabling rapid biomarker cutoff optimizationBudczies, Jan ; Klauschen, Frederick ; Sinn, Bruno V ; Győrffy, Balázs ; Schmitt, Wolfgang D ; Darb-Esfahani, Silvia ; Denkert, Carsten van Diest, PaulPloS one, 2012-12, Vol.7 (12), p.e51862-e51862 [Periódico revisado por pares]United States: Public Library of ScienceTexto completo disponível |
|
8 |
Material Type: Artigo
|
Assessment of Ki67 in Breast Cancer: Updated Recommendations From the International Ki67 in Breast Cancer Working GroupNielsen, Torsten O ; Leung, Samuel C. Y ; Rimm, David L ; Dodson, Andrew ; Acs, Balazs ; Badve, Sunil ; Denkert, Carsten ; Ellis, Matthew J ; Fineberg, Susan ; Flowers, Margaret ; Kreipe, Hans H ; Laenkholm, Anne-Vibeke ; Pan, Hongchao ; Penault-Llorca, Frédérique M ; Polley, Mei-Yin ; Salgado, Roberto ; Smith, Ian E ; Sugie, Tomoharu ; Bartlett, John M. S ; McShane, Lisa M ; Dowsett, Mitch ; Hayes, Daniel FJNCI : Journal of the National Cancer Institute, 2021-07, Vol.113 (7), p.808-819 [Periódico revisado por pares]United States: Oxford University PressTexto completo disponível |
|
9 |
Material Type: Artigo
|
Update on tumor-infiltrating lymphocytes (TILs) in breast cancer, including recommendations to assess TILs in residual disease after neoadjuvant therapy and in carcinoma in situ: A report of the International Immuno-Oncology Biomarker Working Group on Breast CancerDieci, Maria Vittoria ; Radosevic-Robin, Nina ; Fineberg, Susan ; van den Eynden, Gert ; Ternes, Nils ; Penault-Llorca, Frederique ; Pruneri, Giancarlo ; D’Alfonso, Timothy M. ; Demaria, Sandra ; Castaneda, Carlos ; Sanchez, Joselyn ; Badve, Sunil ; Michiels, Stefan ; Bossuyt, Veerle ; Rojo, Federico ; Singh, Baljit ; Nielsen, Torsten ; Viale, Giuseppe ; Kim, Seong-Rim ; Hewitt, Stephen ; Wienert, Stephan ; Loibl, Sybille ; Rimm, David ; Symmans, Fraser ; Denkert, Carsten ; Adams, Sylvia ; Loi, Sherene ; Salgado, RobertoSeminars in cancer biology, 2018-10, Vol.52 (Pt 2), p.16-25 [Periódico revisado por pares]England: Elsevier LtdTexto completo disponível |
|
10 |
Material Type: Artigo
|
Specific microRNA signatures in exosomes of triple-negative and HER2-positive breast cancer patients undergoing neoadjuvant therapy within the GeparSixto trialStevic, Ines ; Müller, Volkmar ; Weber, Karsten ; Fasching, Peter A ; Karn, Thomas ; Marmé, Frederic ; Schem, Christian ; Stickeler, Elmar ; Denkert, Carsten ; van Mackelenbergh, Marion ; Salat, Christoph ; Schneeweiss, Andreas ; Pantel, Klaus ; Loibl, Sibylle ; Untch, Michael ; Schwarzenbach, HeidiBMC medicine, 2018-10, Vol.16 (1), p.179-179, Article 179 [Periódico revisado por pares]England: BioMed Central LtdTexto completo disponível |